These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 730385)

  • 1. Modification of surface composition of Actinomyces viscosus T14V and T14AV.
    Powell JT; Fischlschweiger W; Birdsell DC
    Infect Immun; 1978 Dec; 22(3):934-44. PubMed ID: 730385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the virulence-associated antigen on the surface fibrils of Actinomyces viscosus T14.
    Cisar JO; Vatter AE; McIntire FC
    Infect Immun; 1978 Jan; 19(1):312-9. PubMed ID: 624593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological, chemical and antigenic characterization of M-1 N-acetylmuramidase-digested cell walls of the oral pathogenic bacterium Actinomyces viscosus T14V and T14AV.
    Brown DA; Fischlschweiger W; Birdsell DC
    Arch Oral Biol; 1982; 27(3):183-91. PubMed ID: 6953934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface fibrils (fimbriae) of Actinomyces viscosus T14V.
    Cisar JO; Vatter AE
    Infect Immun; 1979 May; 24(2):523-31. PubMed ID: 88416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fimbriae of Actinomyces viscosus t14v: their relationship to the virulence-associated antigen and to coaggregation with Streptococcus sanguis 34.
    Cisar JO; McIntire FC; Vatter AE
    Adv Exp Med Biol; 1978; 107():695-701. PubMed ID: 84522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence of Actinomyces viscosus T14V and T14AV to hydroxyapatite surfaces in vitro and human teeth in vivo.
    Wheeler TT; Clark WB; Birdsell DC
    Infect Immun; 1979 Sep; 25(3):1066-74. PubMed ID: 500185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological, chemical, and antigenic characterization of cell walls of the oral pathogenic strains Actinomyces viscosus T14V and T14AV.
    Brown DA; Fischlschweiger W; Birdsell DC
    Arch Oral Biol; 1980; 25(7):451-7. PubMed ID: 6935993
    [No Abstract]   [Full Text] [Related]  

  • 8. Specific absence of type 2 fimbriae on a coaggregation-defective mutant of Actinomyces viscosus T14V.
    Cisar JO; Curl SH; Kolenbrander PE; Vatter AE
    Infect Immun; 1983 May; 40(2):759-65. PubMed ID: 6132880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of physicochemical parameters on adsorption of Actinomyces viscosus to hydroxyapatite surfaces.
    Wheeler TT; Clark WB; Lane MD; Grow TE
    Infect Immun; 1983 Mar; 39(3):1095-101. PubMed ID: 6840836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical characterization of extracellular polysaccharides produced by Actinomyces viscosus T14V and T14Av.
    Imai S; Kuramitsu H
    Infect Immun; 1983 Mar; 39(3):1059-66. PubMed ID: 6840834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model studies on dental plaque formation: deoxyhexoses in Actinomyces viscosus.
    Tylenda CA; Charon D; Lombardi FP; Gabriel O
    Infect Immun; 1979 Feb; 23(2):312-9. PubMed ID: 570555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of extracellular slime production by Actinomyces viscosus.
    Ooshima T; Kuramitsu HK
    Infect Immun; 1981 Jun; 32(3):1105-12. PubMed ID: 7251159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of lytic bacteriophage for Actinomyces viscosus T14V as a probe for cell surface components mediating intergeneric coaggregation.
    Delisle AL; Donkersloot JA; Kolenbrander PE; Tylenda CA
    Infect Immun; 1988 Jan; 56(1):54-9. PubMed ID: 3335409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibril-mediated adherence of Actinomyces viscosus to saliva-treated hydroxyapatite.
    Wheeler TT; Clark WB
    Infect Immun; 1980 May; 28(2):577-84. PubMed ID: 7399676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of coaggregation between Actinomyces viscosus T14V and Streptococcus sanguis 34.
    McIntire FC; Vatter AE; Baros J; Arnold J
    Infect Immun; 1978 Sep; 21(3):978-88. PubMed ID: 30701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface localization of sialic acid on Actinomyces viscosus.
    Jones AH; Lee CC; Moncla BJ; Robinovitch MR; Birdsell DC
    J Gen Microbiol; 1986 Dec; 132(12):3381-91. PubMed ID: 3655719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic control of serum antibody responses of inbred mice to type 1 and type 2 fimbriae from Actinomyces viscosus T14V.
    Haber J; Grinnell CM; Beem JE; Clark WB
    Infect Immun; 1991 Jul; 59(7):2364-9. PubMed ID: 1675628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of surface fimbriae (fibrils) in the adsorption of Actinomyces species to saliva-treated hydroxyapatite surfaces.
    Clark WB; Webb EL; Wheeler TT; Fischlschweiger W; Birdsell DC; Mansheim BJ
    Infect Immun; 1981 Sep; 33(3):908-17. PubMed ID: 6169645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservation of an Actinomyces viscosus T14V type 1 fimbrial subunit homolog among divergent groups of Actinomyces spp.
    Yeung MK
    Infect Immun; 1992 Mar; 60(3):1047-54. PubMed ID: 1347285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against the Ag2 fimbriae of Actinomyces viscosus T14V inhibit lactose-sensitive bacterial adherence.
    Revis GJ; Vatter AE; Crowle AJ; Cisar JO
    Infect Immun; 1982 Jun; 36(3):1217-22. PubMed ID: 6124506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.